Rhythm Pharmaceuticals Netherlands Clinical Trials

Company details

Status: Public
HQ: BRIGHTLANDS CHEMELOT CAMPUS, VAN ITERSON BUILDING, BURGEMEESTER LEMMENSSTRAAT 352, Geleen, nl
Founded: 2014
Employees: 10
Programs: 73
Drugs: 38
Patents: 12

Official website ↗ All projects Drug pipeline Patents News & analysis

Recent trial activity

8 updates

Latest clinical program signals indexed for Rhythm Pharmaceuticals Netherlands.

Trial registry

79 studies

NCT00147277
Implantable Cardiac Defibrillator

Approved completed other

Tachycardia, Ventricular

CT.gov ↗
NCT00147290
Implantable Cardiac Defibrillator

Approved completed other

Tachycardia, Ventricular

CT.gov ↗
NCT00157768
Implantable cardioverter defibrillator

Approved completed other

Acute Myocardial Infarction

CT.gov ↗
NCT00157781
Medtronic AT500

Approved completed other

Atrial Fibrillation

CT.gov ↗
NCT00157794
Search AV+ algorithm

Approved terminated other

Arrhythmia, Sinus

CT.gov ↗
NCT00157846
CRT-P or CRT-D Device

Approved terminated other

Heart Failure, Congestive

CT.gov ↗
NCT00170261
Use of an Implantable Loop Recorder

Approved completed other

Syncope

CT.gov ↗
NCT00170287
ICD Ablation plus VT-ablation

Approved completed other

Tachycardia, Ventricular

CT.gov ↗
NCT00170313
Conducted AF-Response Algorithm (CAFR) On

Approved terminated other

Heart Failure

CT.gov ↗
NCT00262119
Pacemaker Medtronic EnRhythm

Approved completed other

Atrial Fibrillation

CT.gov ↗
NCT00293241
Managed Ventricular Pacing programmed ON/OFF

Approved completed other

Cardiovascular Diseases

CT.gov ↗
NCT00359203
Dual chamber pacemeker

Approved completed other

Syncope

CT.gov ↗
NCT00476957
Stent

Approved completed other

Ischemic Heart Disease

CT.gov ↗
NCT00480077
20061016-V2

Approved terminated other

Heart Failure

CT.gov ↗
NCT00514735
Class I or III Antiarrhythmic Medications

Phase 3 completed small_molecule

Atrial Fibrillation

CT.gov ↗
NCT00523978
Flecainide or Sotalol or Propafenone

Phase 3 completed small_molecule

Paroxysmal Atrial Fibrillation

CT.gov ↗
NCT00525356
Medtronic Talent Stent-Graft-System

Phase 3 completed other

Aortic Diseases

CT.gov ↗
NCT00551499
CRT + AOP

Approved completed other

Heart Failure

CT.gov ↗
NCT00617084
Medtronic Endeavor Resolute

Approved completed other

Coronary Artery Disease

CT.gov ↗
NCT00617175
Implantable Defibrillator

Approved completed other

Heart Disease

CT.gov ↗
NCT00621621
Freezor® Cardiac Cryoablation Catheter CryoConsole System

Approved completed other

Tachycardia, Atrioventricular Nodal Reentry

CT.gov ↗
NCT00631709
CareLink Remote Monitoring

Approved completed other

Pacemaker

CT.gov ↗
NCT00744835
Ablation procedure and/or cardioversion

Phase 1 completed other

Atrial Fibrillation

CT.gov ↗
NCT00744874
RF Ablation procedure

Approved completed other

Paroxysmal Atrial Fibrillation

CT.gov ↗
NCT00769457
Access Arm

Approved completed other

Heart Failure

CT.gov ↗
NCT00821938
LV dp/dt pressure measurement

Approved completed other

Heart Failure

CT.gov ↗
NCT00839566
Ablation

Approved terminated other

Atrial Fibrillation

CT.gov ↗
NCT00846001
Coronary artery bypass grafting

Phase 3 completed other

Ischemic Heart Failure

CT.gov ↗
NCT00847288
Monthly Review Arm

Approved completed other

Heart Failure

CT.gov ↗
NCT00887237
CRT with triple site ventricular stimulation

Phase 3 completed other

Heart Failure

CT.gov ↗
NCT00924638
Reveal® XT Insertable Cardiac Monitor

Approved completed other

Cryptogenic Symptomatic Transient Ischemic Attack

CT.gov ↗
NCT01037426
Fill out Questionnaire

Approved completed other

Bradycardia

CT.gov ↗
NCT01074671
CG Future Annuloplasty Ring/Band

Approved completed other

Mitral Valve Insufficiency

CT.gov ↗
NCT01112579
Medtronic PrimeADVANCED Neurostimulator

Phase 2 completed other

Heart Failure

CT.gov ↗
NCT01213251
Single Site Pacing

Phase 2 completed other

Acute Myocardial Infarction

CT.gov ↗
NCT01288352
early standardised rhythm control

Approved completed other

Atrial Fibrillation

CT.gov ↗
NCT01362465
Cardiac Resynchronization Therapy

Phase 1 completed other

Heart Failure

CT.gov ↗
NCT01365234
Pacing Lead

Phase 1 completed other

Heart Failure

CT.gov ↗
NCT01370564
Diuretics

Phase 2 completed small_molecule

Heart Failure

CT.gov ↗
NCT01434615
CRT

Approved completed other

Heart Failure

CT.gov ↗
NCT01458483
Baroreceptor Stimulation

Phase 1 completed other

Hypertension

CT.gov ↗
NCT01539161
Implantable Cardiac Monitor

Approved terminated other

Chagas Disease

CT.gov ↗
NCT01645917
Arctic Front Advance Cardiac CryoAblation system

Approved completed other

Paroxysmal Atrial Fibrillation

CT.gov ↗
NCT01749137
Setmelanotide

Phase 2 completed small_molecule

Overweight

CT.gov ↗
NCT01867437
Placebo

Phase 1 completed small_molecule

Obesity

CT.gov ↗
NCT01944228
Vagal Nerve Stimulation

Phase 1 completed other

Inflammation

CT.gov ↗
NCT02041195
Setmelanotide

Phase 2 completed small_molecule

Overweight and Obesity

CT.gov ↗
NCT02277990
TYRX™ Absorbable Antibacterial Envelope

Approved completed other

CIED Related Infection

CT.gov ↗
NCT02311673
Setmelanotide

Phase 2 active small_molecule

Prader-Willi Syndrome

CT.gov ↗
NCT02358603
Chronotropic Incompetence Diagnostic Algorithm

Unknown terminated other

Heart Failure

CT.gov ↗
NCT02431442
RM-493

Phase 1 completed small_molecule

Overweight

CT.gov ↗
NCT02492243
PCI

Phase 2 completed other

Myocardial Infarction

CT.gov ↗
NCT02666742
DOAC

Approved completed small_molecule

Ventricular Tachycardia

CT.gov ↗
NCT02896192
Setmelanotide

Phase 3 completed small_molecule

Pro-opiomelanocortin (POMC) Deficiency Obesity

CT.gov ↗
NCT03013543
Setmelanotide

Phase 2 completed small_molecule

Genetic Obesity

CT.gov ↗
NCT03035227
Anti-Arrhythmics

Approved terminated small_molecule

Arrhythmia, Cardiac

CT.gov ↗
NCT03157297
MARVEL algorithm

Phase 1 completed other

Atrioventricular Conduction Block

CT.gov ↗
NCT03262610
Setmelanotide

Phase 2 completed small_molecule

Hypertriglyceridemia

CT.gov ↗
NCT03287960
Setmelanotide

Phase 3 completed small_molecule

Leptin Receptor Deficiency Obesity

CT.gov ↗
NCT03651765
Setmelanotide

Phase 3 active small_molecule

Obesity Associated With Defects in Leptin-melanocortin Pathway

CT.gov ↗
NCT03746522
Setmelanotide

Phase 3 completed small_molecule

Bardet Biedl Syndrome (BBS)

CT.gov ↗
NCT03884504
Ventricular Assist Device System

Phase 3 completed other

Heart Failure

CT.gov ↗
NCT04348175
Setmelanotide

Phase 1 completed small_molecule

Renal Insufficiency

CT.gov ↗
NCT04473807
KCHRF-DASH-AF-0002

Approved active small_molecule

Arrhythmias, Cardiac

CT.gov ↗
NCT04725240
Setmelanotide

Phase 3 active small_molecule

Hypothalamic Obesity

CT.gov ↗
NCT04963231
Setmelanotide

Phase 2 completed small_molecule

Genetic Obesity

CT.gov ↗
NCT04966741
Setmelanotide

Phase 3 completed small_molecule

Bardet-Biedl Syndrome

CT.gov ↗
NCT05046132
Setmelanotide

Approved completed small_molecule

Healthy

CT.gov ↗
NCT05093634
Setmelanotide

Phase 3 active small_molecule

Obesity

CT.gov ↗
NCT05194124
Setmelanotide 2 mg

Phase 3 completed small_molecule

Bardet-Biedl Syndrome

CT.gov ↗
NCT05575999
Bupivacaine alone OR Bupivacaine-Ketorolac-Ketamine (BKK) Combination

Phase 1 active small_molecule

Pain Management

CT.gov ↗
NCT05774756
Setmelanotide

Phase 3 active small_molecule

Hypothalamic Obesity

CT.gov ↗
NCT06046443
LB54640

Phase 2 completed small_molecule

Hypothalamic Obesity

CT.gov ↗
NCT06174220
Tideglusib

Phase 2 active small_molecule

Arrhythmogenic Cardiomyopathy

CT.gov ↗
NCT06239116
Part A: RM-718 or placebo (matched to specific RM-718 dose cohort)

Phase 2 active small_molecule

Hypothalamic Obesity

CT.gov ↗
NCT06596135
Setmelanotide

Phase 3 active small_molecule

Obesity Associated With Defects in Leptin-melanocortin Pathway

CT.gov ↗
NCT06760546
Setmelanotide

Phase 3 active small_molecule

Hypothalamic Obesity

CT.gov ↗
NCT06772597
Setmelanotide

Phase 2 active small_molecule

Prader-Willi Syndrome

CT.gov ↗
NCT07156578
Bivamelagon

Phase 2 active small_molecule

Hypothalamic Obesity

CT.gov ↗

Recent trial activity

Trial registry

Stay Ahead in Pharma